F
Finch Therapeutics Group
A clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs
About Finch Therapeutics Group
Finch Therapeutics is a biotechnology company focused on developing microbiome-based therapeutics. The company operates in the healthcare and pharmaceutical market, targeting conditions such as recurrent C. difficile infection, chronic hepatitis B, inflammatory bowel disease, and autism-related gastrointestinal symptoms. Finch's unique approach involves utilizing data from human interventional studies and a machine learning-based platform to understand the microbiome communities that drive positive clinical outcomes. This 'Human First' discovery platform allows Finch to start drug development with a clinical understanding rather than a purely laboratory-based approach. The business model primarily revolves around research and development, clinical trials, and partnerships with other pharmaceutical companies. Finch generates revenue through the development and commercialization of its therapeutic products, as well as through collaborations and licensing agreements. The company's clients include healthcare providers, patients, and pharmaceutical partners.
Source: Dealroom company dataNews
Open roles
Finch Therapeutics Group in the Boston ecosystem
The Finch Therapeutics Group office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Shumway Capital
Avenir Growth Capital- MNMorgan Noble
Series B and later11 investors entered at this stage
OCV Partners
Trans Pacific Technology Fund
Willett Advisors
The Baupost Group
Humboldt Fund
MSD Partners
OMX Ventures
SIG Group
DFO Management
SymBiosis
Octave Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Finch Therapeutics Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Finch Therapeutics Group on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


